Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Amphotericin B: side effects and toxicity
2009548 citationsRafael Laniado-Laborı́n et al.Revista Iberoamericana de Micologíaprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Rafael Laniado-Laborı́n
Since
Specialization
Citations
This map shows the geographic impact of Rafael Laniado-Laborı́n's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Laniado-Laborı́n with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Laniado-Laborı́n more than expected).
Fields of papers citing papers by Rafael Laniado-Laborı́n
This network shows the impact of papers produced by Rafael Laniado-Laborı́n. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Laniado-Laborı́n. The network helps show where Rafael Laniado-Laborı́n may publish in the future.
Co-authorship network of co-authors of Rafael Laniado-Laborı́n
This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Laniado-Laborı́n.
A scholar is included among the top collaborators of Rafael Laniado-Laborı́n based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Rafael Laniado-Laborı́n. Rafael Laniado-Laborı́n is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Laniado-Laborı́n, Rafael, et al.. (2009). Amphotericin B: side effects and toxicity. Revista Iberoamericana de Micología. 26(4). 223–227.548 indexed citations breakdown →
Laniado-Laborı́n, Rafael, et al.. (2007). Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally.. PubMed. 11(3). 289–92.13 indexed citations
15.
Laniado-Laborı́n, Rafael. (2006). Coccidioidomicosis: Más que una enfermedad regional. Revista del Instituto Nacional de Enfermedades Respiratorias. 19(4). 301–308.11 indexed citations
16.
Laniado-Laborı́n, Rafael, et al.. (2005). No siempre una baciloscopía positiva indica tuberculosis: Otra razón para solicitar cultivos rutinariamente. Revista del Instituto Nacional de Enfermedades Respiratorias. 18(4). 286–289.
Laniado-Laborı́n, Rafael, et al.. (2002). Coexistencia de tuberculosis y coccidioidomicosis. Presentación de dos casos clínicos. Revista del Instituto Nacional de Enfermedades Respiratorias. 15(2). 98–101.10 indexed citations
20.
Laniado-Laborı́n, Rafael, Craig A. Molgaard, & John P. Elder. (1993). [The effectiveness of a program of smoking prevention among Mexican schoolchildren].. PubMed. 35(4). 403–8.10 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.